Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Thoratec Corp (NASDAQ:THOR)

Wednesday’s trading has closed, but THOR is being traded in the after-hours session. After-Hours quote »
63.12
Delayed Data
As of 3:59pm ET
 +0.02 / +0.03%
Today’s Change
22.50
Today|||52-Week Range
63.51
+94.45%
Year-to-Date

Today’s Trading

Previous close63.10
Today’s open63.17
Day’s range62.89 - 63.27
Volume1,152,595
Average volume (3 months)978,284
Market cap$3.4B
Dividend yield--
Data as of 3:59pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)-29.37%
Earnings growth (this year)-7.19%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)-5.02%
P/E ratio82.4
Price/Sales3.87
Price/Book5.40

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...-1.09-2.18%
CMNCantel Medical Corp-0.51-0.94%
PCRXPacira Pharmaceutica...-0.98-1.64%
CNMDConmed Corp-0.67-1.16%
Data as of 3:59pm ET, 07/29/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$0.29
Annual revenue (last year)$477.6M
Annual profit (last year)$50.4M
Net profit margin10.55%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
D. Keith Grossman
Chief Financial Officer &
Vice President
Taylor C. Harris
Corporate headquarters
Pleasanton, California

Forecasts